John Kildea

Title:

Dr

Academic title(s):

Associate Member, Medical Physics Unit; Department of Physics; Department of Biomedical Engineering, McGill University

Medical Physicist, McGill University Health Centre

Associate Professor, Gerald Bronfman Department of Oncology

Scientist, Cancer Research Program, RI-MUHC

John Kildea

Contact Information

Email address:

john.kildea [at] mcgill.ca

Address:

Cedars Cancer Centre, Medical Physics, DS1.4561
McGill University Health Centre - Glen Site
1001 boul. Décarie
Montréal, QC H4A 3J1

Phone:

(514) 934-1934 x44154

Group:

Assistant Professor

Degree(s):

BSc, Physics (Queen's Belfast '98)

PhD, Astrophysics (Dublin '03)

Postdoc, Astrophysics (McGill '06)

Postdoc, Astrophysics (Harvard '08)

MSc, Medical Physics (McGill '10)

Residency, Radiotherapy (McGill '12)

Location:

Glen Hospital

Current research:

Opal Health Informatics Group (O-HIG)

I lead the Opal Health Informatics Group at the RI-MUHC. O-HIG is the research team that designed, developed, clinically implemented and actively supports the Opal patient portal at the MUHC.

Radiation Oncology Knowledge Sharing (ROKS)

The ROKS group is undertaking informatics research projects in radiation oncology in which the retrospective data of patients previously treated with radiotherapy are used to predict treatments and outcomes of new patients.

Neutron Induced Carcinogenic Effects (NICE)

The NICE research team is examining the biphysics underlying the energy dependence of the neutron radiation weighting factors.

Areas of interest:

Health informatics, radiation safety, patient-centered care, radiation-oncology knowledge sharing.

Selected publications:

Chu et al., "Acceptability of a Patient Portal (Opal) in HIV Clinical Care: A Feasibility Study" Journal of Personalized Medicine (2021)

Mohsen* et al., “Exploring Cancer Patients’ Perceptions of Accessing and Experience with Using the Educational Material in the Opal Patient Portal” Supportive Care in Cancer (2021).

Sepulveda* et al., “Implementation of a DVH Registry to provide constraints and continuous quality monitoring for pediatric CSI treatment planning” Journal of Applied Clinical Medical Physics (2020).

H. Patrick* et al., "A Canadian Response to the Coronavirus Disease 2019 (COVID-19) Pandemic: Is There a Silver Lining for Radiation Oncology Patients?." Advances in Radiation Oncology 5.4 (2020): 774.

H. Patrick*, et al., "Reduction of inter-observer contouring variability in daily clinical practice through a retrospective, evidence-based intervention." Acta Oncologica (2020): 1-8.

F. Mathew* et al., “Development of a passive gold-foil nested neutron spectrometer to validate the active current-mode He-3 measurements in a high neutron fluence rate radiotherapy environment.” Nuclear Instruments and Methods in Physics Research Section A, (2020).

F. Mathew* et al., “The impact of treatment parameter variation on secondary neutron spectra in high-energy electron beam radiotherapy.” European Journal of Medical Physics (2020).

C. Lund* et al., “A microdosimetric analysis of the interactions of mono-energetic neutrons with human tissue”, European Journal of Medical Physics (2020).

L. Montgomery* et al., “A novel MLEM stopping criterion for unfolding neutron fluence spectra in radiation therapy”, NIMA (2020).

J. Kildea, et al., “Design and development of a person-centered patient portal using participatory stakeholder co-design”, JMIR, (2019)

(see Google Scholar for complete list)

Awards, honours, and fellowships:

Member, Canadian College of Medical Physicists (FCCPM), 2012

Back to top